Gadobutrol Alternatives Compared
| Gadobutrol | Dotarem (gadoterate meglumine) | Gadavist (gadobutrol) |
|
|---|
| Gadobutrol | Dotarem (gadoterate meglumine) | Gadavist (gadobutrol) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for CNS Magnetic Resonance Imaging, Diagnosis and Investigation, Vascular Magnetic Resonance Imaging. Gadobutrol may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging. Dotarem may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging, Diagnosis and Investigation, Vascular Magnetic Resonance Imaging. Gadavist may also be used for purposes not listed in this medication guide. |
Related suggestions CNS Magnetic Resonance Imaging
|
|||||||||||||||||||||||
| More about Gadobutrol | More about Dotarem (gadoterate meglumine) | More about Gadavist (gadobutrol) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Gadobutrol has an average rating of 2.2 out of 10 from a total of 9 ratings on Drugs.com. 11% of reviewers reported a positive effect, while 89% reported a negative effect. |
Dotarem has an average rating of 2.9 out of 10 from a total of 8 ratings on Drugs.com. 13% of reviewers reported a positive effect, while 75% reported a negative effect. |
Gadavist has an average rating of 1.3 out of 10 from a total of 8 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Gadobutrol side effects |
View all Dotarem side effects |
View all Gadavist side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Gadobutrol prices |
View all Dotarem prices |
View all Gadavist prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Gadavist | Other gadoterate meglumine brands include: Clariscan |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
2.13 hours |
15.1 hours |
2.13 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 30 drugs are known to interact with Gadobutrol:
|
A total of 40 drugs are known to interact with Dotarem:
|
A total of 30 drugs are known to interact with Gadavist:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
March 14, 2011 |
March 20, 2013 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.